Cellectar plans Phase III start in late Q4 2026 as it outlines potential WM approval in the second half of 2027

The broader AI infrastructure trade

2026/06/26

Central Garden & Pet (CENT): Buy, Sell, or Hold Post Q1 Earnings?

2026/06/26

Ardelyx stock decline attributed to setback in Xphozah appeal

2026/06/26

S&P 500 Index divergence: Equal-weight climbs while cap-weight melts

2026/06/26